Skip to main content
. 2021 Jul 27;9(7):e002844. doi: 10.1136/jitc-2021-002844

Table 2.

Grade 3/4 adverse events occurring in >5% of patients

Grade 3/4 adverse event (>5%) Incidence, n (%)
Infections 12 (32)
Neutropenia 12 (32)
Rash 7 (18)
Peripheral sensory polyneuropathy 5 (13)
Diarrhea 4 (11)
Leukopenia 4 (11)
Thromboembolic event 4 (11)
Vomiting 3 (8)
Fever 3 (8)
Allergic reactions 3 (8)
Syncope 3 (8)
Hypertension 3 (8)
Nausea 2 (5)
Abdominal pain 2 (5)
Sepsis 2 (5)
Lipase increased 2 (5)
Thrombocytopenia 2 (5)